Compare ALC & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALC | GEHC |
|---|---|---|
| Founded | 1945 | 1892 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.9B | 35.8B |
| IPO Year | 2002 | 2022 |
| Metric | ALC | GEHC |
|---|---|---|
| Price | $73.97 | $69.89 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 12 |
| Target Price | $89.38 | ★ $90.83 |
| AVG Volume (30 Days) | 1.4M | ★ 3.1M |
| Earning Date | 05-12-2026 | 04-29-2026 |
| Dividend Yield | ★ 0.29% | 0.20% |
| EPS Growth | N/A | ★ 4.84 |
| EPS | N/A | ★ 4.55 |
| Revenue | N/A | ★ $20,625,000,000.00 |
| Revenue This Year | $8.01 | $7.06 |
| Revenue Next Year | $6.43 | $4.50 |
| P/E Ratio | $38.31 | ★ $15.73 |
| Revenue Growth | N/A | ★ 4.84 |
| 52 Week Low | $71.55 | $57.65 |
| 52 Week High | $99.20 | $89.77 |
| Indicator | ALC | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 32.83 | 35.19 |
| Support Level | $72.28 | $69.68 |
| Resistance Level | $81.84 | $75.49 |
| Average True Range (ATR) | 1.48 | 1.68 |
| MACD | -0.48 | 0.07 |
| Stochastic Oscillator | 8.24 | 16.73 |
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).